{{Rsnum
|rsid=10763546
|Gene=TIMM23B
|Chromosome=10
|position=51536399
|Orientation=plus
|GMAF=0.4692
|Assembly=GRCh37.p2
|GenomeBuild=37.2
|dbSNPBuild=134
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 16.8 | 50.4 | 32.7
| HCB | 23.4 | 52.6 | 24.1
| JPT | 15.9 | 46.9 | 37.2
| YRI | 76.0 | 21.2 | 2.7
| ASW | 54.4 | 36.8 | 8.8
| CHB | 23.4 | 52.6 | 24.1
| CHD | 33.0 | 40.4 | 26.6
| GIH | 41.4 | 41.4 | 17.2
| LWK | 80.0 | 16.4 | 3.6
| MEX | 12.1 | 50.0 | 37.9
| MKK | 71.8 | 26.3 | 1.9
| TSI | 21.8 | 50.5 | 27.7
| HapMapRevision=28
}}

{{Report GE
|PubMed=18264097
|Source=journal
|AffyProbeset=SNP_A-8572122
|AffyOrientation=same
|AlleleA=C
|AlleleB=G
|onGW5=0
|rsid=10763546
|ancestral=C
|RiskPopulation=UK, Australia
|RiskAllele=C
|CaseFreq=
|ControlFreq=
|OddsRatioHet=1.15
|OddsRatioHom=1.99
|OddsRatioAll=
|Disease=Prostate cancer
|DiseaseSymbol=PC
}}

rs10763546 is in linkage disequilibrium with a polymorphism that increases susceptibility to Prostate cancer 1.15 times for heterozygotes (CG) and 1.99 times for homozygotes (CC) {{PMID|18264097}}

rs10763546 is in linkage disequilibrium with a polymorphism that increases susceptibility to Prostate cancer 1.42 times for heterozygotes (CG) and 2.80 times for homozygotes (CC) {{PMID|18264097}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}